Home
About
Product
magNews
Career
Contact Us
中文
English
Search News
Corporate
Industry
Technology
Medical Updates
ECMO
Corporate
magAssist's extracorporeal ventricular assist device (Extra-VAD) was presented in the 2021 Suzhou New District Science and Technology Innovation Exhibition
2021-07-12
Medical Updates
Big country Great Medic|Nianguo Dong's team, pioneer of heart transplantation in China
2021-06-09
Corporate
magAssist ECMO approved in the Transformation of Scientific and Technological Achievements Special Fund
2023-08-28
Corporate
The Cross-Strait Youth Cultural Month Kicks off, as magAssist Engages in a Dialogue with Taiwanese Youth
2023-07-28
Corporate
BreathMo®: The New Generation ECMO system Revealed at ASAIO Conference
2023-07-22
Corporate
MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE
2023-06-17
Corporate
The Chinese Start-Up Advancing Life Support Tech
2023-03-30
Corporate
magAssist Revealed in MedTech Outlook's Top 10 MedTech Companies in APAC Region for 2022
2023-03-14
Corporate
magAssist Gains Recognition for Its Innovation in the Cardiovascular Field at 2022 Critical Heart Disease Congress-International Society for Mechanical Circulatory Support Parallel Forum
2023-01-16
Technology
2022 Critical Heart Disease Congress (CHDC·2022) | “BreathMo® - An Ultra-portable ECMO System” by Dr. Chia Hao Hsu from magAssist Inc.
2023-01-06
《
1
2
3
2/3
》
Tabs:
pVAD,
cardiogenic shock,
external life support systems,
ECMO devices,
IABP,
Bridge-to-recovery,
cardiogenic shock treatment,
MoyoAssist Extra-VAD,
solid technology of artificial hearts,
Awards,
TOP